SENTI BIOSCIENCES
Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Its therapeutics specialize in cell engineering and biological programming to build the future of gene and cell-based therapies that enable physicians to give patients life-saving treatments at an affordable cost.
SENTI BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sentibio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
215.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Font Awesome Apache Nginx Amazon IPv6
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
8VC
8VC investment in Post-IPO Equity - Senti Biosciences
Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy investment in Post-IPO Equity - Senti Biosciences
Leaps by Bayer
Leaps by Bayer investment in Post-IPO Equity - Senti Biosciences
Morgan Stanley Investment Management
Morgan Stanley Investment Management investment in Post-IPO Equity - Senti Biosciences
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Senti Biosciences
Invus
Invus investment in Post-IPO Equity - Senti Biosciences
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Senti Biosciences
Amgen Ventures
Amgen Ventures investment in Post-IPO Equity - Senti Biosciences
Leaps by Bayer
Leaps by Bayer investment in Convertible Note - Senti Biosciences
National Cancer Institute
National Cancer Institute investment in Grant - Senti Biosciences
Key Employee Changes
Official Site Inspections
http://www.sentibio.com Semrush global rank: 4 M Semrush visits lastest month: 3.11 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
